Maria Jose Cuadrado Lozano, Manuel Macia Heras, Jesus Diez Manglano, Angel Robles Marhuenda and Antonio Serrano Hernandez.
The Antiphospholipid Syndrome (APS) One of the topics covered this Friday was in Multidisciplinary Symposium on Systemic Autoimmune Diseases, which is being developed in Madrid. Various experts in the field have excited and discussed the latest antibodies, as well as their treatment and effect on pregnancy.
Antonio Serrano Hernandezspecialist in the Immunology Service at the University Hospital 12 de October (Madrid), addressed the clinical significance of Antiphospholipid antibodies Not included in FAS Standards. An aspect on which there are more and more studies, but for which it has been confirmed that its approach can only be relied upon solid articles.
However, the expert explained that like the usual antiphospholipid antibodies, they also represent patient risk Thus, it has highlighted the importance of continuing to investigate them, just as new diagnostic techniques have emerged to treat them.
Maria Jose Cuadrado Lozanoof the Rheumatology Service of the University Clinic of Navarra (Madrid), spoke for his part about the treatment of antiphospholipid syndrome and the need or not to continue to Anticoagulant therapy forever.
The decision to continue anticoagulant therapy for life depends on the possibility of identifying the source.
Given this assumption, the specialist initially raised the various scenarios that could occur. In this sense, he referred to Venous and arterial thrombosis. Different conditions but ‘probably’ the same indications can be followed, although there is more evidence for the former.
Thus, this was highlighted in the venous thrombosis in which The source cannot be determinedLifelong treatments. A conclusion that changes if there is a specific reason, such as making a decision. ContraceptivesAnd if the factors are favorable to the patient. So it can be discarded.
In the end, she concluded that, in her personal capacity “Will not remove anticoagulants” In unexplained or unattributed thrombosis, although there are other treatments that may be used.
Antiphospholipids during pregnancy
While, Angel Robles Marhuendaof the Internal Medicine Service of the Hospital Universitario La Paz (Madrid), has focused on antiphospholipids during pregnancy. A stage where you should have Special care in diagnosis Each patient can raise it, especially when it appears “dark”.
In this sense, he explained it according to Pregnant characteristicsTaking into account aspects such as age, you can choose different treatments such as heparin, aspirin or hydroxychloroquine.
Although it may contain statements, statements, or notes from health institutions or professionals, the information in medical writing is edited and prepared by journalists. We recommend the reader to consult a health professional with any health-related questions.